DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

All news

Neutral impactCompany

Morepen Laboratories Limited — Investor Presentation

NSE 3 hrs ago·4 Aug 2026, 8:31 am

Company NSE

Morepen Laboratories has submitted a detailed investor presentation to the stock exchanges. This document outlines the company's current business strategy, financial performance, and future growth plans for the coming quarters.

For investors, this update is significant as it provides transparency into management's outlook. It helps shareholders assess the company's direction and potential for value creation amidst a competitive pharmaceutical landscape.

Investors should focus on the guidance provided regarding revenue targets, profit margins, and key product launches. Monitoring the company's execution of these strategies will be crucial for understanding its future trajectory.